Vascular endothelial growth factor D (VEGF-D), also known as c-Fos-induced growth factor, is structurally and functionally related to VEGF-C. VEGF-D initiates signal transduction cascades by binding VEGFR2/Flk-1 and VEGFR3/Flt-4 with similar biological outcomes, including angiogenesis, endothelial cell proliferation and migration, and blood vessel permeability. VEGF-D also modulates venous and lymphatic vascular systems formation during embryogenesis and maintains differentiated lymphatic endothelium in adults. The Human VEGF-D Kit provides the assay-specific components for the quantitative determination of VEGF-D in human serum, plasma, cell supernatant, cerebral spinal fluid, urine, and cell lysate.
-
-
Specifications
-
Kit Contents
-
References
-
Documentation
Application(s)
|
|
Cardiovascular
|
|
Analyte(s)
|
|
VEGF-D
|
|
Species
|
|
Human
|
|
Instrument
|
|
MESO QuickPlex SQ 120
,
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO SECTOR S 600
|
|
Plate Type
|
|
96-well
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
Detection Antibody
|
|
Goat Polyclonal
|
|
LLOD (Sensitivity)
|
|
2.53 pg/mL
|
|
Dynamic Range
|
|
2.53–18 800 pg/mL
|
|
Sample Type
|
|
Serum, EDTA Plasma, Urine, Cell Culture Supernatant, Cell Lysate
|
|
Recombinant standards
|
|
Expressed in Sf21 insect cells
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
≤-70°C
|
1 vial (1 vial)
|
|
|
2-8°C
|
1 vial (75 μL)
|
|
Angiogenesis Panel 1 (human) Plate
|
2-8°C
|
1 each (1 each)
|
|
Diluent Assembly 11 (includes Diluent 7 – 50 mL, Diluent 11 – 5 mL)
|
≤-10°C
|
1 each
|
|
|
RT
|
1 each (50 mL)
|
|
MSD Blocker A
|
RT
|
1 each (250 mL)
|
|
MSD Phosphate Buffer 5X
|
RT
|
1 each (50 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
≤-70°C
|
5 vial (1 vial)
|
|
|
2-8°C
|
1 vial (375 μL)
|
|
Angiogenesis Panel 1 (human) Plate
|
2-8°C
|
5 each (1 each)
|
|
Diluent Assembly 12 (includes Diluent 7 – 50 mL, Diluent 11 – 50 mL)
|
≤-10°C
|
1 each
|
|
|
RT
|
1 each (50 mL)
|
|
MSD Blocker A
|
RT
|
1 each (250 mL)
|
|
MSD Phosphate Buffer 5X
|
RT
|
1 each (50 mL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
≤-70°C
|
25 vial (1 vial)
|
|
|
2-8°C
|
5 vial (375 μL)
|
|
Angiogenesis Panel 1 (human) Plate
|
2-8°C
|
25 each (1 each)
|
|
Diluent Assembly 12 (includes Diluent 7 – 50 mL, Diluent 11 – 50 mL)
|
≤-10°C
|
5 each
|
|
|
RT
|
5 each (50 mL)
|
|
MSD Blocker A
|
RT
|
5 each (250 mL)
|
|
MSD Phosphate Buffer 5X
|
RT
|
5 each (50 mL)
|
|
Title
|
Journal
|
Year
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
|
Product Inserts
|
|
|
Product Highlights
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Kit Layout (Add-in)
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters